Gain Therapeutics (GANX) Q2 2024 Earnings

14MayConfirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-0.62
-0.49
-0.35
-0.22

Details

Expected EPS
-0.3108
Actual EPS
-0.22
Surprise EPS
0.09
Surprise Percent
+29.21%

Description

Gain Therapeutics (GANX) has reported earnings of -0.22 per share for Q2 2024.

0 Comments

Share your thoughts